Literature DB >> 27933441

Multimodality imaging to assess immediate response following irreversible electroporation in patients with malignant hepatic tumors.

Katsutoshi Sugimoto1, Fuminori Moriyasu2, Kazuhiro Saito3, Yoshiyuki Kobayashi4, Takao Itoi4.   

Abstract

PURPOSE: To assess the diagnostic accuracy of contrast-enhanced ultrasound (CEUS), contrast-enhanced multiphase CT (CECT), and gadoxetic acid-enhanced MRI (EOB-MRI) in identifying residual tumor in the subacute follow-up of patients with malignant hepatic tumors treated by irreversible electroporation (IRE).
METHODS: We enrolled 16 patients with 21 hepatic lesions treated by IRE and examined by CEUS and CECT at 1 day after IRE and by EOB-MRI at 7 days after IRE. Follow-up examinations by EOB-MRI or CECT and CEUS were performed at 3-month intervals. Two radiologists independently reviewed the images and assessed the probability of residual tumor using a five-point scale with receiver operating characteristic (ROC) curve analysis. The sensitivity and specificity were also evaluated. Verifiable local recurrence was assessed using follow-up imaging as the reference standard.
RESULTS: The mean area under the ROC curve was significantly higher for CEUS (0.980) than for CECT (0.742, P < 0.01) and EOB-MRI (0.806, P < 0.01), as were the sensitivity and specificity (mean 85.7 and 85.7% for CEUS, respectively, vs 64.3 and 46.4% for CECT and 78.6 and 64.3% for EOB-MRI).
CONCLUSION: CEUS was found to be superior to CECT and EOB-MRI for the diagnosis of residual tumor in the subacute phase following IRE.

Entities:  

Keywords:  CT; IRE; Irreversible electroporation; Liver; MRI; Ultrasound

Mesh:

Substances:

Year:  2016        PMID: 27933441     DOI: 10.1007/s10396-016-0767-0

Source DB:  PubMed          Journal:  J Med Ultrason (2001)        ISSN: 1346-4523            Impact factor:   1.314


  15 in total

1.  Tissue ablation with irreversible electroporation.

Authors:  R V Davalos; I L M Mir; B Rubinsky
Journal:  Ann Biomed Eng       Date:  2005-02       Impact factor: 3.934

Review 2.  Image-guided tumor ablation: standardization of terminology and reporting criteria.

Authors:  S Nahum Goldberg; Clement J Grassi; John F Cardella; J William Charboneau; Gerald D Dodd; Damian E Dupuy; Debra Gervais; Alice R Gillams; Robert A Kane; Fred T Lee; Tito Livraghi; John McGahan; David A Phillips; Hyunchul Rhim; Stuart G Silverman
Journal:  Radiology       Date:  2005-04-21       Impact factor: 11.105

3.  Percutaneous ablation therapy of hepatocellular carcinoma with irreversible electroporation: MRI findings.

Authors:  Vincenza Granata; Roberta Fusco; Orlando Catalano; Mauro Piccirillo; Mario De Bellis; Francesco Izzo; Antonella Petrillo
Journal:  AJR Am J Roentgenol       Date:  2015-05       Impact factor: 3.959

4.  Irreversible electroporation for nonthermal tumor ablation in patients with hepatocellular carcinoma: initial clinical experience in Japan.

Authors:  Katsutoshi Sugimoto; Fuminori Moriyasu; Yoshiyuki Kobayashi; Kazuhiro Saito; Hirohito Takeuchi; Saori Ogawa; Mayumi Ando; Takatomo Sano; Toshifumi Mori; Yoshihiro Furuichi; Ikuo Nakamura
Journal:  Jpn J Radiol       Date:  2015-06-02       Impact factor: 2.374

5.  Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin.

Authors:  Takahide Nakazawa; Shigehiro Kokubu; Akitaka Shibuya; Koji Ono; Masaaki Watanabe; Hisashi Hidaka; Takeshi Tsuchihashi; Katsunori Saigenji
Journal:  AJR Am J Roentgenol       Date:  2007-02       Impact factor: 3.959

6.  Ablation of perivascular hepatic malignant tumors with irreversible electroporation.

Authors:  T Peter Kingham; Ami M Karkar; Michael I D'Angelica; Peter J Allen; Ronald P Dematteo; George I Getrajdman; Constantinos T Sofocleous; Stephen B Solomon; William R Jarnagin; Yuman Fong
Journal:  J Am Coll Surg       Date:  2012-06-16       Impact factor: 6.113

7.  MR monitoring of MR-guided radiofrequency thermal ablation of normal liver in an animal model.

Authors:  T L Boaz; J S Lewin; Y C Chung; J L Duerk; M E Clampitt; J R Haaga
Journal:  J Magn Reson Imaging       Date:  1998 Jan-Feb       Impact factor: 4.813

8.  Integrating contrast-enhanced sonography in the follow-up algorithm of hepatocellular carcinoma treated with radiofrequency ablation: single cancer center experience.

Authors:  Orlando Catalano; Francesco Izzo; Paolo Vallone; Fabio Sandomenico; Vittorio Albino; Antonio Nunziata; Roberta Fusco; Antonella Petrillo
Journal:  Acta Radiol       Date:  2014-02-12       Impact factor: 1.990

9.  The effect of irreversible electroporation on blood vessels.

Authors:  Elad Maor; Antoni Ivorra; Jonathan Leor; Boris Rubinsky
Journal:  Technol Cancer Res Treat       Date:  2007-08

Review 10.  Thermal ablation therapy for hepatocellular carcinoma.

Authors:  Muneeb Ahmed; S Nahum Goldberg
Journal:  J Vasc Interv Radiol       Date:  2002-09       Impact factor: 3.464

View more
  1 in total

Review 1.  A Systematic Review about Imaging and Histopathological Findings for Detecting and Evaluating Electroporation Based Treatments Response.

Authors:  Vincenza Granata; Roberta Fusco; Simona Salati; Antonella Petrillo; Elio Di Bernardo; Roberta Grassi; Raffaele Palaia; Ginevra Danti; Michelearcangelo La Porta; Matteo Cadossi; Gorana Gašljević; Gregor Sersa; Francesco Izzo
Journal:  Int J Environ Res Public Health       Date:  2021-05-24       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.